Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
253 Leser
Artikel bewerten:
(0)

Laboratorio Buena Salud and The National Hispanic Medical Association, Partner up to Provide Better Diagnostic Services to the Latino Community and Physicians

ELMWOOD PARK, N.J., Feb. 8, 2013 /PRNewswire/ --Laboratorio Buena Salud, the only diagnostic laboratory targeting the Latino community and The National Hispanic Medical Association have formally agreed on a strategic partnership to provide access for innovative testing and services to the Hispanic market and NHMA physicians.

"Hispanics represent the largest minority population in the United States and the largest growth of all minority populations," said Richard Rodriguez Marketing Manager of Laboratorio Buena Salud. This is why BioReference Laboratories launched Laboratorio Buena Salud in October 2012, so the Latino community can have a partner who understands their unique health concerns and work toward enhancing their wellbeing.

Dr. Elena Rios, Executive Director of NHMA said, " We are excited about the partnership with Laboratorio Buena Salud. We will be helping them to educate our doctors about this great service that is addressing the health needs of a market that continues to be underserved. Laboratorio Buena Salud has my full support to insure they effectively make our community and doctors aware of its services and how they understand the communities health concerns and can address them in their native language."

Laboratorio Buena Salud andThe National Hispanic Medical Association, will be a great partnership between two companies with the same mission which is to educate and enhance the health and wellbeing of the Hispanic community.

To learn more about Laboratorio Buena Salud and how it can best service the needs of the Latino community or your patients, please visit www.laboratoriobuenasalud.com or call to schedule an appointment with a Physician Representative at 914-220-2271.

Media Relations
Richard Rodriguez
Marketing Manager
(201) 398-5742
rrodriguez@laboratoriobuenasalud.com

To open an Account
Miguel Sanchez
Director of Sales
(914) 220-2271
misanchez@laboratoriobuenasalud.com

About Laboratorio Buena Salud
Laboratorio Buena Salud is a clinical testing laboratory offering testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. Our parent company BioReference Laboratories is the fourth largest full-service laboratory inthe United Statesand the largest independent regional laboratory in the Northeastern market. Laboratorio Buena Salud offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation and treatment of diseases. Laboratorio Buena Salud primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, women's health and correctional health care.

About National Hispanic Medical Association
Established in 1994 in Washington, DC, the National Hispanic Medical Association is a non-profit association representing the interests of 45,000 licensed Hispanic physicians in the United States.

SOURCE Laboratorio Buena Salud

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2013 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.